Literature DB >> 24309297

Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.

Sharon L Nichols1, Amanda Lowe2, Xinrui Zhang3, Patricia A Garvie4, Sarah Thornton5, Bruce A Goldberger2, Wei Hou6, Maureen M Goodenow2, John W Sleasman7.   

Abstract

BACKGROUND: Substance use by youth living with HIV (YLWH) is a concern, given potential interactions with virus-associated immune suppression and adverse effects on risk behaviors, neurocognition, and adherence. Self-report substance use measures provide efficient cost-effective assessments. Analyses describe self-reported substance use among YLWH and examine agreement with toxicology assays.
METHODS: Seventy-eight youth age 18-24 years (87% male, 71% African-American) with behaviorally acquired HIV-1 infection and 55 uninfected youth completed the Alcohol, Smoking, and Substance Involvement Screening Test to assess drug use frequency, including tobacco, marijuana, cocaine, and alcohol, over the prior three months. Elisa-based toxicology assays were used to detect 27 substances in plasma. Chi-square tests compared substance use between YLWH and uninfected youth; Kappa statistics compared agreement between self-report and toxicology.
RESULTS: YLWH reported marijuana (49%), tobacco (56%), and alcohol (87%) use, with 20%, 28% and 3% reporting daily use of each substance, respectively; other substance use was uncommon. Uninfected youth reported less tobacco use but otherwise similar substance use. All youth who reported daily use of marijuana or tobacco had positive plasma toxicology results, while concordance decreased with less frequent self-reported use. Among youth reporting no substance use, few tested positive (4% YLWH, 2% uninfected youth for cannabis; 8%YLWH for tobacco).
CONCLUSIONS: Youth report high rates of marijuana, tobacco, and alcohol use. Concordance between self-report and toxicology for marijuana and tobacco use, particularly for daily users, supports self-report as a valid indicator of substance use in research studies of youth with or without HIV-1 infection.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent; HIV; Marijuana; Self-report; Substance use; Toxicology

Mesh:

Year:  2013        PMID: 24309297      PMCID: PMC4006963          DOI: 10.1016/j.drugalcdep.2013.11.010

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  29 in total

1.  Concordance between verbal report and urine screen of recent marijuana use in adolescents.

Authors:  I H Akinci; R E Tarter; L Kirisci
Journal:  Addict Behav       Date:  2001 Jul-Aug       Impact factor: 3.913

2.  Discrepancies between women's personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases, and HIV infection.

Authors:  P O'Campo; M A de Boer; R R Faden; A C Gielen; N Kass; R Chaisson
Journal:  Med Care       Date:  1992-10       Impact factor: 2.983

3.  Validity of adolescent self-report of substance use.

Authors:  Robert J Williams; Nadine Nowatzki
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

4.  Are adolescents accurate in self-report of frequencies of sexually transmitted diseases and pregnancies?

Authors:  L R Clark; C Brasseux; D Richmond; P Getson; L J D'Angelo
Journal:  J Adolesc Health       Date:  1997-08       Impact factor: 5.012

5.  Tobacco-reporting validity in an epidemiological drug-use survey.

Authors:  Michael Fendrich; Mary Ellen Mackesy-Amiti; Timothy P Johnson; Amy Hubbell; Joseph S Wislar
Journal:  Addict Behav       Date:  2005-01       Impact factor: 3.913

6.  Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis.

Authors:  D A Murphy; S Durako; L R Muenz; C M Wilson
Journal:  Am J Epidemiol       Date:  2000-11-01       Impact factor: 4.897

7.  The changing pattern of substance abuse in urban adolescents.

Authors:  C Brasseux; L J D'Angelo; M Guagliardo; J Hicks
Journal:  Arch Pediatr Adolesc Med       Date:  1998-03

8.  Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum.

Authors:  Monica S Webb; Peter A Vanable; Michael P Carey; Donald C Blair
Journal:  J Behav Med       Date:  2007-06-15

Review 9.  The influence of substance use on adolescent brain development.

Authors:  L M Squeglia; J Jacobus; S F Tapert
Journal:  Clin EEG Neurosci       Date:  2009-01       Impact factor: 1.843

10.  Working and episodic memory in HIV infection, alcoholism, and their comorbidity: baseline and 1-year follow-up examinations.

Authors:  Rosemary Fama; Margaret J Rosenbloom; B Nolan Nichols; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2009-07-28       Impact factor: 3.455

View more
  17 in total

1.  A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.

Authors:  Kristi E Gamarel; Sharon Nichols; Christopher W Kahler; Andrew O Westfall; Michelle A Lally; Craig M Wilson
Journal:  Sex Transm Infect       Date:  2017-11-27       Impact factor: 3.519

2.  Validation of a substance and alcohol use assessment instrument among orphans and vulnerable children in Zambia using Audio Computer Assisted Self-Interviewing (ACASI).

Authors:  Jeremy C Kane; Laura K Murray; Judith K Bass; Renee M Johnson; Paul Bolton
Journal:  Drug Alcohol Depend       Date:  2016-06-29       Impact factor: 4.492

3.  Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

Authors:  Julie C Williams; Sofia Appelberg; Bruce A Goldberger; Thomas W Klein; John W Sleasman; Maureen M Goodenow
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-23       Impact factor: 4.147

4.  Psychological symptoms among 2032 youth living with HIV: a multisite study.

Authors:  Larry K Brown; Laura Whiteley; Gary W Harper; Sharon Nichols; Amethys Nieves
Journal:  AIDS Patient Care STDS       Date:  2015-01-13       Impact factor: 5.078

5.  The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.

Authors:  Kristi E Gamarel; Kimberly M Nelson; Larry Brown; M Isabel Fernandez; Sharon Nichols
Journal:  AIDS Behav       Date:  2017-07

6.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.

Authors:  Bret J Rudy; Bill G Kapogiannis; Carol Worrell; Kathleen Squires; James Bethel; Su Li; Craig M Wilson; Allison Agwu; Patricia Emmanuel; Georgine Price; Stephanie Hudey; Maureen M Goodenow; John W Sleasman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

7.  Profiles of Risk Among HIV-Infected Youth in Clinic Settings.

Authors:  M Isabel Fernández; Heather C Huszti; Patrick A Wilson; Shoshana Kahana; Sharon Nichols; René Gonin; Jiahong Xu; Bill G Kapogiannis
Journal:  AIDS Behav       Date:  2015-05

8.  The Impact of Juvenile Drug Treatment Courts on Substance Use, Mental Health, and Recidivism: Results from a Multisite Experimental Evaluation.

Authors:  Steven Belenko; Michael Dennis; Matthew Hiller; Juliette Mackin; Chelsey Cain; Doris Weiland; Barbara Estrada; Raanan Kagan
Journal:  J Behav Health Serv Res       Date:  2022-06-22       Impact factor: 1.475

9.  Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.

Authors:  Julie C Williams; Xinrui Zhang; Manju Karki; Yueh-Yun Chi; Shannon M Wallet; Bret J Rudy; Sharon L Nichols; Maureen M Goodenow; John W Sleasman
Journal:  J Leukoc Biol       Date:  2018-01-29       Impact factor: 4.962

10.  The Role of Behavioral and Neurocognitive Functioning in Substance Use Among Youth with Perinatally Acquired HIV Infection and Perinatal HIV Exposure Without Infection.

Authors:  Sharon L Nichols; Sean Brummel; Kathleen M Malee; Claude A Mellins; Anna-Barbara Moscicki; Renee Smith; Anai M Cuadra; Kendall Bryant; Cheryl Anne Boyce; Katherine K Tassiopoulos
Journal:  AIDS Behav       Date:  2021-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.